FDA advisers consider changing COVID vaccine to target latest omicron strain
The COVID-19 vaccines could undergo a significant alteration by this fall, as FDA advisers are deliberating on whether the next round of vaccinations should specifically target the most recent strains of the Omicron variant that have become globally dominant. Read More: https://abcnews.go.com/Health/wireStory/fda-advisers-changing-covid-vaccine-target-latest-omicron-100105715